Staphylococcus aureus

Mechanisms of Resistance
Impact of Bacterial Membrane Fatty Acid Composition on the Failure of Daptomycin To Kill Staphylococcus aureus
Rym Boudjemaa, Clément Cabriel, Florence Dubois-Brissonnet, Nicolas Bourg, Guillaume Dupuis, Alexandra Gruss, Sandrine Lévêque-Fort, Romain Briandet, Marie-Pierre Fontaine-Aupart, Karine Steenkeste
Mechanisms of Action: Physiological Effects
Exposure of Staphylococcus aureus to Targocil Blocks Translocation of the Major Autolysin Atl across the Membrane, Resulting in a Significant Decrease in Autolysis
Kiran B. Tiwari, Craig Gatto, Suzanne Walker, Brian J. Wilkinson
Susceptibility
The Novel Phage-Derived Antimicrobial Agent HY-133 Is Active against Livestock-Associated Methicillin-Resistant Staphylococcus aureus
Ursula Kaspar, Jorge A. de Haro Sautto, Sonja Molinaro, Georg Peters, Evgeny A. Idelevich, Karsten Becker
Pharmacology
Activities of Combinations of Antistaphylococcal Antibiotics with Fusidic Acid against Staphylococcal Biofilms in In Vitro Static and Dynamic Models
Wafi Siala, Hector Rodriguez-Villalobos, Prabhavathi Fernandes, Paul M. Tulkens, Françoise Van Bambeke
Letter to the Editor
Increasing Rates of Penicillin Sensitivity in Staphylococcus aureus
Guillaume Butler-Laporte, Todd C. Lee, Matthew P. Cheng
Experimental Therapeutics
Tomatidine Is a Lead Antibiotic Molecule That Targets Staphylococcus aureus ATP Synthase Subunit C
Maxime Lamontagne Boulet, Charles Isabelle, Isabelle Guay, Eric Brouillette, Jean-Philippe Langlois, Pierre-Étienne Jacques, Sébastien Rodrigue, Ryszard Brzezinski, Pascale B. Beauregard, Kamal Bouarab, Kumaraswamy Boyapelly, Pierre-Luc Boudreault, Éric Marsault, François Malouin
Experimental Therapeutics
In Vitro and In Vivo Activities of DS-2969b, a Novel GyrB Inhibitor, and Its Water-Soluble Prodrug, DS11960558, against Methicillin-Resistant Staphylococcus aureus
Tarani Kanta Barman, Manoj Kumar, Tarun Mathur, Eiko Namba, Diksha Singh, Tridib Chaira, Yuichi Kurosaka, Makiko Yamada, Dilip Jatashankar Upadhyay, Nobuhisa Masuda
Experimental Therapeutics
The Combination of Daptomycin and Fosfomycin Has Synergistic, Potent, and Rapid Bactericidal Activity against Methicillin-Resistant Staphylococcus aureus in a Rabbit Model of Experimental Endocarditis
Cristina García-de-la-Mària, Oriol Gasch, Javier García-Gonzalez, Dolors Soy, Evelyn Shaw, Juan Ambrosioni, Manel Almela, Juan M. Pericàs, Adrián Tellez, Carlos Falces, Marta Hernandez-Meneses, Elena Sandoval, Eduard Quintana, Barbara Vidal, Jose M. Tolosana, David Fuster, Jaume Llopis, Miquel Pujol, Asuncion Moreno, Francesc Marco, Jose M. Miró
and the Hospital Clinic Endocarditis Study Group
Mechanisms of Action: Physiological Effects
β-Lactam Combinations with Vancomycin Show Synergistic Activity against Vancomycin-Susceptible Staphylococcus aureus, Vancomycin-Intermediate S. aureus (VISA), and Heterogeneous VISA
Kieu-Nhi Tran, Michael J. Rybak
Epidemiology and Surveillance
Clinical and Genetic Risk Factors for Biofilm-Forming Staphylococcus aureus
Megan K. Luther, Diane M. Parente, Aisling R. Caffrey, Kathryn E. Daffinee, Vrishali V. Lopes, Emily T. Martin, Kerry L. LaPlante

Main menu

User menu

Search

Staphylococcus aureus

Pages